Killing cancer cells by rupturing their lysosomes
- PMID: 32203434
- DOI: 10.1038/s41565-020-0639-z
Killing cancer cells by rupturing their lysosomes
Comment on
-
Targeted crystallization of mixed-charge nanoparticles in lysosomes induces selective death of cancer cells.Nat Nanotechnol. 2020 Apr;15(4):331-341. doi: 10.1038/s41565-020-0643-3. Epub 2020 Mar 16. Nat Nanotechnol. 2020. PMID: 32203435
Similar articles
-
Targeted crystallization of mixed-charge nanoparticles in lysosomes induces selective death of cancer cells.Nat Nanotechnol. 2020 Apr;15(4):331-341. doi: 10.1038/s41565-020-0643-3. Epub 2020 Mar 16. Nat Nanotechnol. 2020. PMID: 32203435
-
Mediators of inflammation in leukocyte lysosomes. VI. Partial purification and characterization of a mast cell-rupturing component.J Exp Med. 1966 Nov 1;124(5):833-49. doi: 10.1084/jem.124.5.833. J Exp Med. 1966. PMID: 5926298 Free PMC article.
-
Lysosomotropic agents. 1. Synthesis and cytotoxic action of lysosomotropic detergents.J Med Chem. 1979 Sep;22(9):1130-3. doi: 10.1021/jm00195a026. J Med Chem. 1979. PMID: 114658
-
Crystals, lysosomes and gout.Adv Intern Med. 1974;19:239-57. Adv Intern Med. 1974. PMID: 4592714 Review. No abstract available.
-
Destination 'lysosome': a target organelle for tumour cell killing?J Mol Recognit. 2003 Sep-Oct;16(5):337-48. doi: 10.1002/jmr.643. J Mol Recognit. 2003. PMID: 14523947 Review.
Cited by
-
Increased endocytosis rate and enhanced lysosomal pathway of silica-coated superparamagnetic nanoparticles into M-HeLa cells compared with cultured primary motor neurons.Histochem Cell Biol. 2024 Jun;161(6):507-519. doi: 10.1007/s00418-024-02283-z. Epub 2024 Apr 10. Histochem Cell Biol. 2024. PMID: 38597938
-
Research Progress on Nucleus-Targeting Carbon Nanoparticles for Tumor Imaging and Therapy.Int J Nanomedicine. 2025 Aug 5;20:9695-9721. doi: 10.2147/IJN.S520205. eCollection 2025. Int J Nanomedicine. 2025. PMID: 40785951 Free PMC article. Review.
-
Lysosome-derived biomarkers for predicting survival outcome in acute myeloid leukemia.Discov Oncol. 2025 Aug 2;16(1):1455. doi: 10.1007/s12672-025-03302-8. Discov Oncol. 2025. PMID: 40751887 Free PMC article.
-
Mechanisms of immune response to inorganic nanoparticles and their degradation products.Adv Drug Deliv Rev. 2022 Jan;180:114022. doi: 10.1016/j.addr.2021.114022. Epub 2021 Nov 2. Adv Drug Deliv Rev. 2022. PMID: 34740764 Free PMC article. Review.
-
RBC-derived vesicles as a systemic delivery system of doxorubicin for lysosomal-mitochondrial axis-improved cancer therapy.J Adv Res. 2020 Nov 24;30:185-196. doi: 10.1016/j.jare.2020.11.009. eCollection 2021 May. J Adv Res. 2020. PMID: 34026295 Free PMC article.
References
-
- Sun, T. et al. Angew. Chem. Int. Ed. 53, 12320–12364 (2014).
-
- Shi, J., Kantoff, P. W., Wooster, R. & Farokhzad, O. C. Nat. Rev. Cancer 17, 20–37 (2017). - DOI
-
- Lammers, T. et al. Nat. Rev. Mater. 1, 16069 (2016). - DOI
-
- Wilhelm, S. et al. Nat. Rev. Mater. 1, 16014 (2016). - DOI
-
- Borkowska, M. et al. Nat. Nanotechnol. https://doi.org/10.1038/s41565-020-0643-3 (2020).
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical